BRIEF published on 04/14/2026 at 17:45, 12 days 16 hours ago Carvolix: Number of shares and voting rights as of March 31, 2026 Euronext Paris Share Capital Voting Rights Medical Afflict Carvolix
BRIEF published on 04/09/2026 at 07:35, 18 days 2 hours ago Carvolix strengthens its governance bodies Innovation Board Of Directors Governance Medical Technologies Carvolix
BRIEF published on 04/09/2026 at 07:35, 18 days 2 hours ago Carvolix Strengthens Its Leadership Team Board Of Directors Medical Technology AI-driven Technology Leadership Appointments Carvolix
PRESS RELEASE published on 04/09/2026 at 07:30, 18 days 2 hours ago Carvolix Strengthens its Board of Directors, and International Advisory Bodies Carvolix strengthens its Board of Directors and International Advisory Bodies, appointing new members including Anne Lange and Rute Fernandes to enhance governance and leadership structures Board Of Directors Carvolix International Advisory Bodies Anne Lange Rute Fernandes
BRIEF published on 03/23/2026 at 17:50, 1 month 3 days ago Carvolix is included in Euronext indices, strengthening its financial visibility Investors Euronext Medical Technology CAC Indices Carvolix
BRIEF published on 03/23/2026 at 17:50, 1 month 3 days ago Carvolix Joins Euronext Indices, Enhancing Market Profile AI-driven Technology Investor Visibility Carvolix Euronext Indices Medical Robots
PRESS RELEASE published on 03/23/2026 at 17:45, 1 month 3 days ago Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile. Carvolix joins key Euronext indices, marking a new milestone in its capital markets profile Capital Markets Milestone Carvolix AI-driven Mini-robots Euronext Indices
BRIEF published on 03/19/2026 at 17:50, 1 month 7 days ago Carvolix: Strategic Transformation and 2025 Financial Results 2025 Financial Results Carvolix Medical Robotics TAVIPILOT Interventional Cardiology
BRIEF published on 03/19/2026 at 17:50, 1 month 7 days ago Carvolix: Strategic Growth in Medical Robotics and Financial Highlights Financial Results Strategic Acquisitions Biomimetic Implants Medical Robotics TAVIPILOT Software
PRESS RELEASE published on 03/19/2026 at 17:45, 1 month 7 days ago Carvolix : Estimated full-year 2025 results. Carvolix reports estimated full-year 2025 results, highlighting strategic focus on medical robotics and cardiovascular implants. Financial milestones, acquisitions, and future plans outlined Full-year Results Financial Milestones Carvolix Medical Robotics Cardiovascular Implants
Published on 04/27/2026 at 09:40, 20 minutes ago Macau Pass Unveils AI Payment Assistant to Upgrade Local Payment Capabilities
Published on 04/25/2026 at 03:10, 2 days 6 hours ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 2 days 11 hours ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:00, 2 days 12 hours ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 2 days 19 hours ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/27/2026 at 09:05, 55 minutes ago OneLayer Launches Sentry Partner Program to Extend Zero Trust Security for Private Cellular Networks
Published on 04/27/2026 at 09:00, 59 minutes ago Original-Research: THE NAGA GROUP AG (von NuWays AG): BUY
Published on 04/27/2026 at 09:00, 59 minutes ago Original-Research: GFT Technologies SE (von NuWays AG): BUY
Published on 04/27/2026 at 09:00, 59 minutes ago Original-Research: ATOSS Software SE (von NuWays AG): BUY
Published on 04/24/2026 at 17:45, 2 days 16 hours ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 2 days 17 hours ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 3 days 14 hours ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 3 days 15 hours ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
